Planning Application: 235763 (Cork County Council )
File Number:
235763
Application Type:
PERMISSION
Planning Status:
APPLICATION FINALISED
Received Date:
30/08/2023
Decision Due Date:
24/10/2023
Validated Date:
07/09/2023
Invalidated Date:
Further Info Requested:
Further Info Received:
Withdrawn Date:
Extend Date:
Decision Type:
Conditional
Decision Date:
24/10/2023
Leave to Appeal:
Appeal Date:
Commenced Date:
Submissions By:
03/10/2023
Applicant Details
Applicant name:
ELi Lilly Kinsale Limited
Applicant Address:
Phone Number:
Fax Number:
Corresp.
Address:
Applicant Details
Proposed Development
Development Description:
Permission for the construction of a pedestrian footbridge across an existing stream within the Eli Lily pharmaceutical facility, and associated works. The bridge will have a length of approx. 17.9m (13.1 span plus landing areas of 2.4m at either end) and a two-way 2.4m wide walkway and will be located on a site area of approx. 0.23ha. The application site falls within the Eli Lilly industrial complex, which operates under an Industrial Emissions (IE) licence (P0009-04) under part IV of the Environmental Protection Agency Act 1992 (as amended by the protection of the Environmental Act, 2003) and is also an establishment to which the Chemicals Act (Control of Major Accident Hazards involving Dangerous Substances) Regulations 2015 (S.I. 209 of 2015) applies
Development Address:
Eli Lilly Pharmaceutical Complex, Ballythomas East & Ballythomas West, Dunderrow, Kinsale, Co. Cork
Architect Name:
Location Key:
BALLYTHOMAS WEST
Electoral Division:
Planner:
Social Housing Exempt:
Plan Enforcement #:
IPC
Licence Required:
Waste Licence Required:
Protected Structure:
Protected Structure #:
Development Name:
Proposed Development
Comments
Significant Case Flag:
No
Comments:
Decision
Decision Date:
24/10/2023
Manager Order:
5586
Decision Type:
Conditional
Number of Conditions:
8
Grant Date:
01/12/2023
Grant Managers Order #:
Section 47
Apply?:
Part 5
Apply?:
No
Expiry Date:
Decision Description:
Permission for the construction of a pedestrian footbridge across an existing stream within the Eli Lily pharmaceutical facility, and associated works. The bridge will have a length of approx. 17.9m (13.1 span plus landing areas of 2.4m at either end) and a two-way 2.4m wide walkway and will be located on a site area of approx. 0.23ha. The application site falls within the Eli Lilly industrial complex, which operates under an Industrial Emissions (IE) licence (P0009-04) under part IV of the Environmental Protection Agency Act 1992 (as amended by the protection of the Environmental Act, 2003) and is also an establishment to which the Chemicals Act (Control of Major Accident Hazards involving Dangerous Substances) Regulations 2015 (S.I. 209 of 2015) applies
